Evolent Health, Inc Class A Common Stock (EVH) — 分析摘要
Evolent Health, Inc Class A Common Stock（EVH）的市值为480.50百万美元，最近一年的营收同比增长了-26.6%。净利润率为-28.5%。当前市盈率为-1.0倍。
核心要点
- 营收同比变化-26.6%
- 净利润率-28.5%
- 市盈率-1.0倍
与SERVICES-MANAGEMENT SERVICES板块的其他公司相比，EVH的营收增长为-26.6%，市盈率为-1.0倍。
Evolent Health, Inc Class A Common Stock (EVH)
前收盘价 2026-10-12 · 市场数据 POLYGON · 财务数据 SEC EDGAR
红旗与风险提示高风险信号
存在多项实质性红旗，在依赖任何估值输出前应先重点核查这些风险。
利息保障倍数为 -6.2x — 盈利不足以覆盖利息支出
营业利润率为 -20.4% — 经营亏损显著
净利率为 -24.1% — 亏损显著
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
行业
SERVICES-MANAGEMENT SERVICES
员工人数
4,200
总部
ARLINGTON, VA
Exchange
XNYS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析，不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。